Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin.

  • Authors : Sun T; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. .; Mao W

Subjects: Sorafenib*/Sorafenib*/Sorafenib*/pharmacology; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*physiology

  • Source: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2021 Jun; Vol. 44 (3), pp. 689-699. Date of Electronic Publication: 2021 Mar 03.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer.

  • Authors : Xian L; Department of Epidemiology, Faculty of Navy Medicine, Second Military Medical University, Shanghai, 200433, China.; Zhao P

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy

  • Source: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2022 Oct; Vol. 45 (5), pp. 1019-1036. Date of Electronic Publication: 2022 Aug 29.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.

  • Authors : Yu Z; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, No.528. Zhangheng Road, Pudong New District, Shanghai, People's Republic of China. .; Feng H

Subjects: Proteolysis*/Proteolysis*/Proteolysis*/drug effects; Bufanolides/Bufanolides/Bufanolides/*pharmacology ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*virology

  • Source: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2020 Dec; Vol. 43 (6), pp. 1129-1145. Date of Electronic Publication: 2020 Jul 04.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.

  • Authors : Reiter FP; Department of Medicine II, Liver Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, D-81377, Munich, Germany.; Denk G

Subjects: Aminopyridines/Aminopyridines/Aminopyridines/*pharmacology ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism

  • Source: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2019 Oct; Vol. 42 (5), pp. 705-715. Date of Electronic Publication: 2019 Jun 27.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1.

  • Authors : D'Alessandro R; Laboratory of Cellular and Molecular Biology, Department of Clinical Pathology, National Institute of Gastroenterology, 'S. De Bellis' Research Hospital, Via Turi 27, 70013, Castellana Grotte, BA, Italy.; Refolo MG

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*drug therapy ; Cell Movement/Cell Movement/Cell Movement/*drug effects

  • Source: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2018 Jun; Vol. 41 (3), pp. 283-296. Date of Electronic Publication: 2018 Feb 22.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report.

  • Authors : Gao L; Department of Oral Biology, Dental College of Georgia, Augusta University, 1120 15th Street, Augusta, GA, 30912, USA.; Shay C

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism ; Fibroblast Growth Factors/Fibroblast Growth Factors/Fibroblast Growth Factors/*metabolism

  • Source: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2018 Feb; Vol. 41 (1), pp. 85-91. Date of Electronic Publication: 2017 Oct 05.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma.

  • Authors : Zhang Y; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan Dongdan, Dongcheng District, Beijing, 100730, China.; Li Y

Subjects: Asian People*; Bone Neoplasms/Bone Neoplasms/Bone Neoplasms/*secondary ; Carcinoma, Renal Cell/Carcinoma, Renal Cell/Carcinoma, Renal Cell/*drug therapy

  • Source: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2016 Feb; Vol. 39 (1), pp. 15-21. Date of Electronic Publication: 2015 Nov 23.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

NMR-Based Metabolic Profiling Reveals Neurochemical Alterations in the Brain of Rats Treated with Sorafenib.

  • Authors : Du C; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, #1 Keyuan Road 4, Gaopeng Street, High-tech Development Zone, Chengdu, 610041, China.; Shao X

Subjects: Metabolomics*; Brain/Brain/Brain/*metabolism ; Niacinamide/Niacinamide/Niacinamide/*analogs & derivatives

  • Source: Neurotoxicity research [Neurotox Res] 2015 Nov; Vol. 28 (4), pp. 290-301. Date of Electronic Publication: 2015 Aug 02.Publisher: Springer Country of Publication: United States NLM ID: 100929017 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
  • 1-10 of  29 نتائج ل ""SORAFENIB""